Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/14/21
End: 04/30/23
Due: 04/30/24
Phase: N/A
Priority: Normal
Start: 10/25/17
End: 12/30/18
Due: 12/30/19
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 02/01/29
Due: 02/01/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment | NCT04946682 | Wen-hong Zhang | user2@example.com | None | 2021-04-14 | 2023-04-30 | 2024-04-30 | - | - | 2025-07-14 |
| Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients | NCT03448744 | Wen-hong Zhang | user2@example.com | None | 2017-10-25 | 2018-12-30 | 2019-12-30 | - | - | 2025-07-14 |
| Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy | NCT05965388 | Wen-hong Zhang | user2@example.com | None | 2023-12-01 | 2029-02-01 | 2030-02-01 | - | - | 2025-07-14 |